NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
Clinical Trials
15 trialsNCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT06684509 2024-11-12
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Assiut University
Phase 1/2 Not yet recruiting
NCT06270667 2024-03-22
LYMfit
Norwegian School of Sport Sciences
Phase NA Recruiting
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated
NCT05728632 2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3 Unknown
NCT00854568 2014-08-20
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Phase 3 Completed
NCT00005578 2014-07-24
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT00002827 2013-08-26
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT01095926 2013-06-28
Doxo
University Hospital Muenster
Phase 2 Completed
NCT01230983 2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3 Completed